Coagulatory Defects in Type-1 and Type-2 Diabetes

被引：55
|
作者：
Sobczak, Amelie I. S. [1 ]
Stewart, Alan J. [1 ]
机构：
[1] Univ St Andrews, Sch Med, Med & Biol Sci Bldg, St Andrews KY16 9TF, Fife, Scotland
来源：
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES | 2019年 / 20卷 / 24期
关键词：
atherosclerosis; endothelial dysfunction; magnesium; metal ions; microparticles; platelets; thrombosis; zinc; CHOLESTEROL EFFLUX CAPACITY; CORONARY-HEART-DISEASE; TISSUE FACTOR PATHWAY; ACTIVATABLE FIBRINOLYSIS INHIBITOR; ERYTHROCYTE-DERIVED MICROPARTICLES; DENSITY-LIPOPROTEIN FUNCTION; CARDIOVASCULAR-DISEASE; INSULIN-RESISTANCE; GLYCEMIC CONTROL; THROMBIN GENERATION;
D O I：
10.3390/ijms20246345
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Diabetes (both type-1 and type-2) affects millions of individuals worldwide. A major cause of death for individuals with diabetes is cardiovascular diseases, in part since both types of diabetes lead to physiological changes that affect haemostasis. Those changes include altered concentrations of coagulatory proteins, hyper-activation of platelets, changes in metal ion homeostasis, alterations in lipid metabolism (leading to lipotoxicity in the heart and atherosclerosis), the presence of pro-coagulatory microparticles and endothelial dysfunction. In this review, we explore the different mechanisms by which diabetes leads to an increased risk of developing coagulatory disorders and how this differs between type-1 and type-2 diabetes.
引用
收藏
页数：27
相关论文
共 50 条
  • [1] ETIOLOGY OF TYPE-1 AND TYPE-2 DIABETES - AN OVERVIEW
    CAMERON, DP
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1988, 18 (03): : 391 - 391
  • [2] Therapy of Type-1 and Type-2 Diabetes mellitus
    Weber, Sonja
    ERNAHRUNGS UMSCHAU, 2009, 56 (10): : 576 - 580
  • [3] PROGRESSION OF PROTEINURIA IN TYPE-1 AND TYPE-2 DIABETES
    COOPER, ME
    FRAUMAN, A
    OBRIEN, RC
    SEEMAN, E
    MURRAY, RML
    JERUMS, G
    DIABETIC MEDICINE, 1988, 5 (04) : 361 - 368
  • [4] TYPE-1 AND TYPE-2 DIABETES AND RENAL REPLACEMENT THERAPY
    CATALANO, C
    BIONDI, B
    FABRIZI, F
    DIABETIC MEDICINE, 1989, 6 (01) : 86 - 86
  • [5] Type-2 diabetes family history delays the onset of type-1 diabetes
    Zalloua, P
    Shbaklo, H
    Halaby, G
    Terwedow, H
    Xu, X
    Azar, ST
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (07): : 3192 - 3196
  • [6] Diabetes Mellitus and Pregnancy. Type-1 and Type-2 Diabetes, Gestation Diabetes
    Kleinwechter, H.
    Schaefer-Graf, U.
    DIABETOLOGIE UND STOFFWECHSEL, 2008, 3 (05) : R69 - R88
  • [7] ERRORS, TYPE-1 AND TYPE-2
    BROWN, GW
    AMERICAN JOURNAL OF DISEASES OF CHILDREN, 1983, 137 (06): : 586 - 591
  • [8] TYPE-1 AND TYPE-2 ADMINISTRATORS
    SLACK, WV
    M D COMPUTING, 1990, 7 (02): : 69 - 70
  • [9] PHAGOCYTIC-ACTIVITY IN CHILDREN WITH TYPE-1 AND TYPE-2 DIABETES
    LOVRENCIC, MK
    RABATIC, S
    SABIONCELLO, A
    OBERITER, V
    BELLO, ID
    DEKARIS, D
    PERIODICUM BIOLOGORUM, 1983, 85 : 175 - 176
  • [10] Glucose Measurement and -Control in Patients with Type-1 or Type-2 Diabetes
    Heinemann, Lutz
    Deiss, Dorothee
    Siegmund, Thorsten
    Schlueter, Sandra
    Naudorf, Michael
    von Sengbusch, Simone
    Lange, Karin
    Freckmann, Guido
    DIABETOLOGE, 2019, 15 (06): : 549 - 567
12345